The Reverse Phase Protein Microarray Platform: A High-Throughput Screening Method for Today's Precision Medicine Needs

Co-hosted by Emory Comprehensive Glycomics Core
Event Date

Join us April 21st, 2020 | 11:00am EDT


Click to register and reserve your spot today!


Join us as Dr. Denes Agoston discusses Reverse Phase Protein Arrays (RPPA), which have been successfully used in various aspects of neurology research.
RPPA is a robust, sensitive, and high throughput analytical platform that can be adapted to many other fields of biomedical research.
This presentation will discuss the advantages and challenges using the RPPA technology.


Speaker: Denes Agoston, MD, PhD
Founder and Chief Medical Officer of Neurometix LLC
Consulting and advising biopharmaceuticals in drug discovery and validation for CNS disorders.

 

Interested in learning more about RPPA technology in action? Watch our informative video on the Quanterix 2470 Arrayer.

This website uses cookies. By continuing to use this website you are acknowledging and agree with our cookie policy.

AgreeLearn more